CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
54 hedge funds and large institutions have $103M invested in Concert Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+3
Holders Change %
+5.88%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
14
Reduced
13
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SAM
Senzar Asset Management
New York
|
+$8.06M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
+$4.68M |
| 3 |
QF
QVT Financial
New York
|
+$3.38M |
| 4 |
Millennium Management
New York
|
+$3.23M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.85M |
Top Sellers
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$3.82M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$3.54M |
| 3 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$1.44M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.29M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$1.27M |
